Hemodialysis patients are surviving longer and enjoying better overall health than at any time in the past. The result has been the highlighting of quality-of-life issues not previously addressed. This case study of the use of sildenafil (Viagra®) in four dialysis patients showed an average improvement of more than 1 point on 13 of 15 questions using the International Index of Erectile Dysfunction, and an average net improvement of more than 22 points in overall score. The outcome of this small study of sildenafil use in the treatment of erectile dysfunction of dialyzed end-stage renal failure patients provides early evidence that the drug is successful in this population.
|Original language||English (US)|
|Number of pages||7|
|Journal||Dialysis and Transplantation|
|State||Published - Sep 1 1999|
ASJC Scopus subject areas